Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...

PTC PTC underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...

Get a deeper insight into the potential performance of PTC Inc. (PTC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for ...

PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

The long-awaited Bunyoro University (BU) in Hoima district remains stalled due to political interference, blackmail and ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Stocks extended their gains on Tuesday on strength in megacap technology stocks. Stocks moved higher Tuesday despite the US imposing a 10% tariff on Chinese goods.  China retaliated immediately and ...

Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...

PointCast Solutions were developed to counter the high costs, inefficiencies, and delays of traditional VSAT deployment and ...